Daiken Biomedical Co., Ltd. (TPE:7780)
Taiwan · Delayed Price · Currency is TWD 24.20
-0.20 (-0.82%)
At close: Feb 11, 2026
Daiken Biomedical Market Cap
Daiken Biomedical has a market cap or net worth of 19.6 billion as of February 20, 2026. Its market cap has increased by 84.57% in one year.
Market Cap
19.60B
Enterprise Value
14.56B
Revenue
1.78B
Ranking
n/a
PE Ratio
55.39
Stock Price
24.20
Market Cap Chart
Since October 28, 2024, Daiken Biomedical's market cap has increased from 10.68B to 19.60B, an increase of 83.54%. That is a compound annual growth rate of 60.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 19.60B | 34.82% |
| Dec 31, 2025 | 14.54B | 33.88% |
| Dec 31, 2024 | 10.86B | 1.69% |
| Oct 28, 2024 | 10.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Charoen Pokphand Enterprise (Taiwan) | 43.78B |
| Great Wall Enterprise | 43.01B |
| Lian Hwa Foods | 27.91B |
| Standard Foods | 26.75B |
| TTET Union | 23.92B |
| Microbio | 10.85B |
| Tehmag Foods | 10.54B |
| Ve Wong | 9.53B |